Sensitive ASX Announcement

Independent Research Validates Biotron HCV Drug Candidate

Published: 27/11/13, 10:18am (AEST)2 pages
Biotron Limited
BIT:ASXHealthcare

Recent BIT Announcements

Price Sensitive only